Citation Impact
Citing Papers
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Designed protein logic to target cells with precise combinations of surface antigens
2020 StandoutScienceNobel
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Bispecific antibodies for cancer therapy
2009
T Cell Memory Against Colon Carcinoma Is Long-Lived in the Absence of Antigen
1999
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates
2016
De novo design of immunoglobulin-like domains
2022 StandoutNobel
Properties, production, and applications of camelid single-domain antibody fragments
2007
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
2002
Engineering precision nanoparticles for drug delivery
2020 Standout
Cytokines in inflammatory bowel disease
2014 Standout
Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy
2018
A novel DNA vaccine encoding PDGFRβ suppresses growth and dissemination of murine colon, lung and breast carcinoma
2006
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth
2002
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
A De Novo Protein Binding Pair By Computational Design and Directed Evolution
2011 StandoutNobel
Reactions in Droplets in Microfluidic Channels
2006 Standout
Toxicity management for patients receiving novel T-cell engaging therapies
2013
Selection and evolution of enzymes from a partially randomized non-catalytic scaffold
2007 StandoutNatureNobel
Immunological applications of single-domain llama recombinant antibodies isolated from a naïve library
2009
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Generation of a Family-specific Phage Library of Llama Single Chain Antibody Fragments That Neutralize HIV-1
2010
Facile labelling of an anti-epidermal growth factor receptor Nanobody with 68Ga via a novel bifunctional desferal chelate for immuno-PET
2011
Strictly Target Cell-dependent Activation of T Cells by Bispecific Single-chain Antibody Constructs of the BiTE Class
2007
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Selecting and screening recombinant antibody libraries
2005
The Tumor Targeted Superantigen ABR-217620 Selectively Engages TRBV7-9 and Exploits TCR-pMHC Affinity Mimicry in Mediating T Cell Cytotoxicity
2013
Kinetic analysis of novel mono‐ and multivalent VHH‐fragments and their application for molecular imaging of brain tumours
2010
Engineered antibodies
2003
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Antibody targeted drugs as cancer therapeutics
2006
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library
2003
CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis
2006
Engineering interferons and interleukins for cancer immunotherapy
2022
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
2013
Two common structural motifs for TCR recognition by staphylococcal enterotoxins
2016 StandoutNobel
Protein‐Detecting Microarrays: Current Accomplishments and Requirements
2005
Elimination of large tumors in mice by mRNA-encoded bispecific antibodies
2017 StandoutNobel
Protein microarray technology
2002
The microenvironment of the tumour–host interface
2001 StandoutNature
Biotechnological applications of recombinant single-domain antibody fragments
2011
Single-domain antibodies as building blocks for novel therapeutics
2008
Kemp elimination catalysts by computational enzyme design
2008 StandoutNatureNobel
Bi-functional cytokine fusion proteins for gene therapy and antibody-targeted treatment of cancer
2002
Myasthenia gravis
2019 Standout
Passive immunization with llama single-domain antibody fragments reduces foot-and-mouth disease transmission between pigs
2009
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Chemistry in living systems
2005 StandoutNobel
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
2015
Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
2018 StandoutNobel
A thermostable Cas9 with increased lifetime in human plasma
2017 StandoutNobel
Neuroblastoma
2007 Standout
Survey of the year 2003 commercial optical biosensor literature
2004
Targeting tumor–stromal interactions in bone metastasis
2013
Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
2016
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
2015
Frequent EpCam protein expression in human carcinomas
2004
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Immuno-imaging using nanobodies
2011
Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage Display
2008
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
2011
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity
2009
Synthesis of Heterobifunctional Protein Fusions Using Copper‐Free Click Chemistry and the Aldehyde Tag
2012 StandoutNobel
Survey of the year 2001 commercial optical biosensor literature
2002
Identification of Human Single-Domain Antibodies against SARS-CoV-2
2020
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C
2005 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Extreme stability in de novo-designed repeat arrays is determined by unusually stable short-range interactions
2018 StandoutNobel
Alternative molecular formats and therapeutic applications for bispecific antibodies
2015
Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy
2004
Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
2012 StandoutNobel
IL-23 Induces Stronger Sustained CTL and Th1 Immune Responses Than IL-12 in Hepatitis C Virus Envelope Protein 2 DNA Immunization
2004
Strategies for extended serum half-life of protein therapeutics
2011
Nanobodies Targeting Mouse/Human VCAM1 for the Nuclear Imaging of Atherosclerotic Lesions
2012
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer
2014
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy
2001
Oral Delivery of Biologics for Precision Medicine
2019
The NMR–Rosetta capsid model of M13 bacteriophage reveals a quadrupled hydrophobic packing epitope
2015 StandoutNobel
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
2010
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
2002
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
2001 StandoutNobel
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis
2004
IFN-γ-Inducible Protein-10 Is Essential for the Generation of a Protective Tumor-Specific CD8 T Cell Response Induced by Single-Chain IL-12 Gene Therapy
2001
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Immunomodulation by Commensal and Probiotic Bacteria
2010
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
2015
pH-Operated Nanopistons on the Surfaces of Mesoporous Silica Nanoparticles
2010 StandoutNobel
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
2008 Science
Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells
2001
Modern Technologies for Creating Synthetic Antibodies for Clinical Application
2009
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients
2004
Synergy between an antiangiogenic integrin αvantagonist and an antibody–cytokine fusion protein eradicates spontaneous tumor metastases
1999
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Lactobacilli Producing Bispecific Llama-Derived Anti-Rotavirus Proteins in vivo for Rotavirus-Induced Diarrhea
2011
Filamentous Phage Display in the New Millennium
2005
N‐Carboxyanhydride Polymerization of Glycopolypeptides That Activate Antigen‐Presenting Cells through Dectin‐1 and Dectin‐2
2018 StandoutNobel
Works of Torsten Dreier being referenced
High-throughput generation and engineering of recombinant human antibodies
2001
Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis
2006
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
2018
In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment
2002
Extremely potent, rapid and costimulation‐independent cytotoxic T‐cell response against lymphoma cells catalyzed by a single‐chain bispecific antibody
2002
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct
2005
Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
2017
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
2009
T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct
2003
Natural Killer Cell–Mediated Eradication of Neuroblastoma Metastases to Bone Marrow by Targeted Interleukin-2 Therapy
1998
Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma
1998
Elimination of established murine colon carcinoma metastases by antibody-interleukin 2 fusion protein therapy.
1997
Improved tumor targeting of anti–epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology
2008
Four individually druggable MET hotspots mediate HGF-driven tumor progression
2014
Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct
2003
Natural Killer Cell–Mediated Eradication of Neuroblastoma Metastases to Bone Marrow by Targeted Interleukin-2 Therapy
1998
Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases.
1998